Hoover Erik T. sold $634K of DD

Hoover Erik T. (SVP & General Counsel) sold 4,203 shares of DuPont de Nemours, Inc. (DD) at $150.82 ($0.63M total) on 2026-11-09.

Original reporting
SEC EDGAR · Hoover Erik T.
Published Nov 9, 2026, 10:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 10:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DD
Bearish
medium confidence
Mentioned
$DD
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DDBearishLow
01

Why it matters

The filing provides the first public disclosure of this insider sale, offering a modest trading cue.

02

Market read

A small‑scale insider sell by a senior executive may cause slight short‑term pressure on DD shares.

03

What to watch

No 10b5‑1 plan; the sale was not pre‑arranged, which may indicate urgency.

Relevance 5/10Novelty 4/10Timing: after‑hours filing today

Background

SEC Form 4 filing discloses an insider transaction by DuPont's senior legal officer.

Company-level read

Ticker impact

$DDBearishMedium confidence
Context

SVP & General Counsel Erik Hoover sold 4,203 DuPont shares for $633,896, reducing his stake to 38,798 shares.

Expected impact

likely slight pressure as the market prices in the insider sell.

Evidence & confidence

C‑suite insider sales are watched by traders; the amount (~$0.6 M) is modest but may prompt short‑term selling.

Market effects

Minimal impact on the chemicals sector; insider activity is company‑specific.

U.S. market only; no broader regional effect.

Low; DuPont is a large cap but the transaction size is small.

Counterpoint

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • DuPont de Nemours, Inc.

    Chemical conglomerate listed on NYSE under ticker DD.

  • Erik T. Hoover

    SVP & General Counsel of DuPont, reporting the insider sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DDMed

Wells Fargo raises DuPont stock price target to $170 on valuation

Wells Fargo raised its price target for DuPont (NYSE:DD) to $170 from $166, maintaining an Overweight rating. The firm cites a higher-quality portfolio and a 2027 EV/EBITDA multiple of 13x. DuPont reported Q3 earnings of $2.09 per share on $1.9B revenue, a 4% increase. UBS also raised its target to $182, citing margin strength. Shares trade at $150.73, with potential upside to $170.

$DDHighAI 9/10

What Just Happened To DuPont Stock?

DuPont (DD) stock rose 8.6% on November 3, 2026, after reporting Q3 2026 earnings of $2.09 per share, beating estimates of $1.87. Sales reached $1.9B, up 4% YoY. The company raised its full-year guidance to $7.50 EPS and $7.19B in sales. Management cited strong order growth but delayed some Middle East projects to 2027. Most peers fell, with only Celanese rising 5.0%.

$DDHighAI 9/10

DuPont de Nemours Q3 Earnings Call Highlights

DuPont (NYSE: DD) reported Q3 Diversified Industrials operating EBITDA up 11% to $242M, with a 24.1% margin. The company highlighted productivity gains, AI initiatives, and raised its 2026 outlook to $7.19B in net sales and $1.785B in EBITDA. Q4 projections include $1.825B in net sales and $455M in EBITDA. DuPont also announced share repurchases and M&A plans.